Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00213148 · ClinicalTrials.gov registry record · Phase 2
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
A Phase 2 study, sponsored by EMD Serono.
- Completed
- Registry status
- Phase 2
- Development phase
- 271
- Enrollment target
NCT00213148 is a Phase 2 study that has completed, run by EMD Serono. The registered enrollment target is 271 participants.
The verdict
NCT00213148, a Phase 2 study, has completed, sponsored by EMD Serono.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 271 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.
Interventions
- DRUG Anastrozole 1 mg
- DRUG Anastrozole 5 mg
- DRUG Anastrozole 10 mg
- DRUG Clomiphene Citrate 50 mg
- DRUG Clomiphene Citrate 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2005-03-10 |
| Est. Completion | 2007-12-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00213148
The ClinicalTrials.gov registry entry for NCT00213148 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Anastrozole 1 mg is the first listed.
NCT00213148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00213148 about?
NCT00213148 is a clinical study titled "Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction". The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.
What is the current status of trial NCT00213148?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 271 participants. The study started on 2005-03-10. Estimated completion is 2007-12-12.
What interventions are being tested in trial NCT00213148?
The interventions under investigation include: Anastrozole 1 mg (DRUG), Anastrozole 5 mg (DRUG), Anastrozole 10 mg (DRUG), Clomiphene Citrate 50 mg (DRUG), Clomiphene Citrate 100 mg (DRUG).
Who is sponsoring clinical trial NCT00213148?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.